cDNA Cloning and Sequencing of a Novel Monoclonal Antibody to Carcinoembryonic Antigen and Construction of a Mouse/Human Chimeric Antibody

Anticancer Research

Volumn 23, Issue 6 A, 2003, Pages 4383-4388

  Shibaguchi, Hirotomo ^a   Arakawa, Fumiko ^a   Imakiire, Takayuki ^a   Kuroki, Motomu ^a   Kuroki, Masahide ^a  

^a FUKUOKA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

ADCC; CEA; Chimeric antibody; Immunotherapy; Monoclonal antibody

Indexed keywords

CARCINOEMBRYONIC ANTIGEN; CHIMERIC ANTIBODY; COMPLEMENTARY DNA; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY F 33 104; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTIGEN BINDING; ANTIGEN EXPRESSION; ANTIGEN SPECIFICITY; BINDING AFFINITY; CELL ACTIVATION; CELL KILLING; CHIMERA; CONFERENCE PAPER; CONTROLLED STUDY; CYTOTOXICITY; DRUG BINDING; DRUG POTENCY; DRUG SPECIFICITY; DRUG SYNTHESIS; GENE FUSION; GENE REPRESSION; GENE SEQUENCE; HUMAN; HUMAN CELL; IMMUNOGENICITY; KILLER CELL; MOLECULAR CLONING; MYELOMA CELL; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS; TUMOR CELL;

AMINO ACID SEQUENCE; ANIMALS; ANTIBODIES, MONOCLONAL; ANTIBODY-DEPENDENT CELL CYTOTOXICITY; BASE SEQUENCE; CARCINOEMBRYONIC ANTIGEN; CELL LINE, TUMOR; DNA, COMPLEMENTARY; FLOW CYTOMETRY; GENE AMPLIFICATION; GENETIC VECTORS; HUMANS; HYBRIDOMAS; IMMUNOGLOBULIN HEAVY CHAINS; IMMUNOGLOBULIN LIGHT CHAINS; IMMUNOGLOBULIN VARIABLE REGION; MICE; MOLECULAR SEQUENCE DATA; RECOMBINANT FUSION PROTEINS; T-LYMPHOCYTES, REGULATORY;

EID: 0344009679     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (20)

1. Primus FJ, Sharkey RM, Hansen HJ and Goldenberg DM: Immunoperoxidase detection of carcinoembryonic antigen. Cancer 42: 1540-1545, 1978.
2. Kuroki Ma, Ueno A, Matsumoto H, Abe H, Li T, Imakiire T, Yamauchi Y, Uno K, Shirota K, Shibaguchi H and Kuroki Mo: Significance of tumor-associated antigens in the diagnosis and therapy of cancer: an overview. Anticancer Res 22: 4255-4264, 2002.
3. Goldenberg DM, Goldenberg H, Sharkey RM, Lee RE, Higgenbotham-Ford E, Horowitz JA, Hall TC, Pinsky CM and Hansen HJ: Imaging of colorectal carcinoma with radiolabeled antibodies. Semin Nucl Med 19: 262-281, 1989.
4. Beatty D: Immunotherapy of colorectal cancer. Cancer 70: 1425-1433, 1992.
5. Ikeda S, Kuroki Ma, Haruno M, Oikawa S, Nakazato H, Kosaki G and Matsuoka Y: Epitope mapping of the carcinoembryonic antigen with various related recombinant proteins expressed in Chinese hamster ovary cells and 25 distinct monoclonal antibodies. Molec Immunol 29: 229-240, 1992.
6. Courtenay-Luck NS, Epenetos AA, Moore R, Larche M, Pectasides D, Dhokia B and Ritter MA: Development of primary and secondary immune responses to mouse monoclonal antibodies used in the diagnosis and therapy of malignant neoplasms. Cancer Res 46: 6489-6493, 1986.
7. Morrison SL, Johnson MJ, Herzenberg LA and Oi VT: Chimeric human antibody molecules: mouse antigen-binding domains with human constant region domains. Proc Natl Acad Sci USA 81: 6851-6855, 1984.
8. Kuroki Ma, Arakawa F, Haruno M, Murakami M, Wakisaka M, Higuchi H, Oikawa S, Nakazato H and Matsuoka Y: Biochemical characterization of 25 distinct carcinoembryonic antigen (CEA) epitopes recognized by 57 monoclonal antibodies and categorized into seven groups in terms of domain structure of the CEA molecule. Hybridoma 11: 391-407, 1992.
9. Arakawa F, Haruno M, Kuroki Ma, Kanda H, Watanabe T, Misumi Y and Matsuoka Y: Construction and expression of two mouse-human chimeric antibodies with high specificity and affinity for carcinoembryonic antigen. Hybridoma 12: 365-379, 1993.
10. Arakawa F, Yamamoto T, Kanda H, Watanabe T and Kuroki Ma: cDNA sequence analysis of monoclonal antibody FU-MK-1 specific for a transmembrane carcinoma-associated antigen, and construction a mouse/human chimeric antibody. Hybridoma 18: 131-138, 1999.
11. Yamamoto T, Arakawa F, Nakamura K, Senba T, Tomita Y, Ikeda S and Kuroki Ma: Enhanced antitumor activity of a combination treatment with a mouse/human chimeric anti-MK-1 antibody and lymphokine-activated killer cells in vitro and in a severe combined immunodeficient mouse xenograft model. Cancer Immunol Immunother 48: 165-171, 1999.
12. Senba T, Kuroki Ma, Arakawa F, Yamamoto T, Kuwahara M, Haruno M, Ikeda S and Matsuoka Y: Tumor growth suppression by a mouse/human chimeric anti-CEA antibody and lymphokine-activated killer cells in vitro and in SCID mouse xenograft model. Anticancer Res 18: 17-24, 1998.
13. Akamizu T, Matsuda F, Okuda J, Li H, Kanda H, Watanabe T, Honjo T and Mori T: Molecular analysis of stimulatory antithyrotropin receptor antibodies (TSAbs) involved in Graves' disease. Isolation and reconstruction of antibody genes, and production of monoclonal TSAbs. J Immunol 157: 3148-3152, 1996.
14. Barnett T and Zimmermann W: Workshop report: Proposed nomenclature for the carcinoembryonic antigen (CEA) gene family. Tumor Biol 11: 59-63, 1990.
15. Kuroki Mo, Abe H, Imakiire T, Liao S, Uchida H, Yamauchi Y, Oikawa S and Kuroki Ma: Identification and comparison of residues critical for cell adhesion activities of two neutrophil CD66 antigens, CEACAM6 and CEACAM8. J Leukocyte Biol 70: 543-550, 2001.
16. Schroff RW, Foon KA, Beatty SM, Oldham RK and Morgan ACJ: Human anti-murine immunoglobulin responses in patients receiving monoclonal antibody therapy. Cancer Res 45: 879-885, 1985.
17. Sakano H, Maki R, Kurosawa Y, Roeder W and Tonegawa S: Two types of somatic recombination are necessary for the generation of complete immunoglobulin heavy-chain genes. Nature 286: 676-683, 1980.
18. Max EE, Maizel JV Jr and Leder P: The nucleotide sequence of a 5.5-kilobase DNA segment containing the mouse kappa immunoglobulin J and C region genes. J Biol Chem 256: 5116-5120, 1981.
19. Steplewski Z, Sun LK, Shearman CW, Ghrayeb J, Daddona P and Koprowski H: Biological activity of human-mouse IgG1, IgG2, IgG3, and IgG4 chimeric monoclonal antibodies with antitumor specificity. Proc Natl Acad Sci USA 85: 4852-4856, 1988.
20. Hale G, Dyer MJS, Clark MR, Phillips JM, Marcus R, Riechmann L Winter G and Waldmann H: Remission induction in non-Hodgkin lymphoma with reshaped human monoclonal antibody CAMPATH-1H. Lancet II: 1394-1399, 1988.